Insmed Incorporated (INSM) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Insmed Incorporated (INSM) is Neutral.

The composite score behind that read is -0.03, weighing +0.23 of bullish evidence against -0.28 bearish.

Insmed Incorporated last closed at $100.60, +0.12% on the session.

Against the IVW growth benchmark the position is -0.68% over the forecast window.

The read is built from 15 underlying insights — 3 bullish and 12 bearish.

Agreement across those insights is 80%.

17 graded predictions for INSM so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Insmed Incorporated in the 10th percentile on return on equity, where 100 is best.

Insmed Incorporated is classified under Health Care / Biotechnology, with a market capitalisation of $21.94B.

StockMap tracks Insmed Incorporated as the 17th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Insmed Incorporated ranks 129th of 381 in the group, against a group median of -0.08.